AGGF1: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
||
| Line 15: | Line 15: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
Revision as of 13:54, 4 September 2012
|
WikiDoc Resources for AGGF1 |
|
Articles |
|---|
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on AGGF1 at Clinical Trials.gov Clinical Trials on AGGF1 at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on AGGF1
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating AGGF1 Risk calculators and risk factors for AGGF1
|
|
Healthcare Provider Resources |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Angiogenic factor with G patch and FHA domains 1, also known as AGGF1, is a human gene.[1]
The VG5Q gene encodes a potent angiogenic factor that contains a forkhead-associated domain and a G-patch domain.[supplied by OMIM][1]
See also
References
Further reading
- Timur AA, Driscoll DJ, Wang Q (2005). "Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis". Cell. Mol. Life Sci. 62 (13): 1434–47. doi:10.1007/s00018-005-4523-7. PMID 15905966.
- Kihiczak GG, Meine JG, Schwartz RA, Janniger CK (2007). "Klippel-Trenaunay syndrome: a multisystem disorder possibly resulting from a pathogenic gene for vascular and tissue overgrowth". Int. J. Dermatol. 45 (8): 883–90. doi:10.1111/j.1365-4632.2006.02940.x. PMID 16911369.
- Dias Neto E, Correa RG, Verjovski-Almeida S; et al. (2000). "Shotgun sequencing of the human transcriptome with ORF expressed sequence tags". Proc. Natl. Acad. Sci. U.S.A. 97 (7): 3491–6. PMID 10737800.
- Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
- Ota T, Suzuki Y, Nishikawa T; et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Tian XL, Kadaba R, You SA; et al. (2004). "Identification of an angiogenic factor that when mutated causes susceptibility to Klippel-Trenaunay syndrome". Nature. 427 (6975): 640–5. doi:10.1038/nature02320. PMID 14961121.
- Callebaut I, Mornon JP (2005). "OCRE: a novel domain made of imperfect, aromatic-rich octamer repeats". Bioinformatics. 21 (6): 699–702. doi:10.1093/bioinformatics/bti065. PMID 15486042.
- Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
- Rual JF, Venkatesan K, Hao T; et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. doi:10.1038/nature04209. PMID 16189514.
- Barker KT, Foulkes WD, Schwartz CE; et al. (2006). "Is the E133K allele of VG5Q associated with Klippel-Trenaunay and other overgrowth syndromes?". J. Med. Genet. 43 (7): 613–4. doi:10.1136/jmg.2006.040790. PMID 16443853.